Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T P Waalkes

Showing results (11-20 of 70) with videos related to

Pageof 7
Sort By:
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 1, 1983
New applications of urinary nucleoside markersE Borek, O K Sharma, T P Waalkes
Cancer Detection and Prevention|January 1, 1983
Tumor markers derived from nucleic acid componentsE Borek, T P Waalkes, C W Gehrke
Progress in Clinical and Biological Research|January 1, 1981
A model for community hospital/regional oncology center collaboration in cancer controlW P Vaughan, T P Waalkes, S Lundahl
JAMA|December 23, 1983
Evaluation of the clinical management of cancer patients. A pilot studyR E Lenhard, T P Waalkes, D Herring
Journal of Chromatography|January 7, 1976
High-resolution liquid chromatographic analysis of methylated purine and pyrimidine bases in transfer RNAD B Lakings, T P Waalkes, J E Mrochek
Journal of the National Cancer Institute|July 1, 1973
Urinary excretion by cancer patients of the nucleosides N-dimethylguanosine, 1-methylinosine, and pseudouridineT P Waalkes, S R Dinsmore, J E Mrochek
International Quarterly of Community Health Education|September 16, 2010
Regionalization of cancer control efforts in the u.s.aT W Elwood, T P Waalkes, W P Vaughan
Journal of Surgical Oncology|January 1, 1980
Biological markers in breast carcinoma--clinical correlations with pseudouridine, N2,N2-dimethylguanosine, and 1-methylinosineD C Tormey, T P Waalkes, C W Gehrke
Cancer|June 1, 1977
Biological markers in breast carcinoma. II. Clinical correlations with human chorionic gonadotrophinD C Tormey, T P Waalkes, R M Simon
Journal of the National Cancer Institute|December 1, 1974
Analytic techniques in the separation and identification of specific purine and pyrimidine degradation products of tRNA: application to urine samples from cancer patientsJ E Mrochek, S R Dinsmore, T P Waalkes
Pageof 7

Showing results (11-20 of 70) with videos related to

Sort By:
Pageof 7
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 1, 1983
New applications of urinary nucleoside markersE Borek, O K Sharma, T P Waalkes
Cancer Detection and Prevention|January 1, 1983
Tumor markers derived from nucleic acid componentsE Borek, T P Waalkes, C W Gehrke
Progress in Clinical and Biological Research|January 1, 1981
A model for community hospital/regional oncology center collaboration in cancer controlW P Vaughan, T P Waalkes, S Lundahl
JAMA|December 23, 1983
Evaluation of the clinical management of cancer patients. A pilot studyR E Lenhard, T P Waalkes, D Herring
Journal of Chromatography|January 7, 1976
High-resolution liquid chromatographic analysis of methylated purine and pyrimidine bases in transfer RNAD B Lakings, T P Waalkes, J E Mrochek
Journal of the National Cancer Institute|July 1, 1973
Urinary excretion by cancer patients of the nucleosides N-dimethylguanosine, 1-methylinosine, and pseudouridineT P Waalkes, S R Dinsmore, J E Mrochek
International Quarterly of Community Health Education|September 16, 2010
Regionalization of cancer control efforts in the u.s.aT W Elwood, T P Waalkes, W P Vaughan
Journal of Surgical Oncology|January 1, 1980
Biological markers in breast carcinoma--clinical correlations with pseudouridine, N2,N2-dimethylguanosine, and 1-methylinosineD C Tormey, T P Waalkes, C W Gehrke
Cancer|June 1, 1977
Biological markers in breast carcinoma. II. Clinical correlations with human chorionic gonadotrophinD C Tormey, T P Waalkes, R M Simon
Journal of the National Cancer Institute|December 1, 1974
Analytic techniques in the separation and identification of specific purine and pyrimidine degradation products of tRNA: application to urine samples from cancer patientsJ E Mrochek, S R Dinsmore, T P Waalkes
Pageof 7